The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Cardlytics Inc shares valued at $50,809 were sold by DeSieno Alexis on May 15 ’25. At $1.94 per share, DeSieno Alexis sold 26,217 shares. The insider’s holdings dropped to 164,833 shares worth approximately $0.29 million following the completion of this transaction.
Also, DeSieno Alexis purchased 26,217 shares, netting a total of over 50,809 in proceeds.
Before that, Lynton Nicholas Hollmeyer had sold 303 shares from its account. In a trade valued at $458, the Chief Legal & Privacy Officer traded Cardlytics Inc shares for $1.51 each. Upon closing the transaction, the insider’s holdings decreased to 303 shares, worth approximately $0.18 million.
As published in their initiating research note from Evercore ISI on October 11, 2024, Cardlytics Inc [CDLX] has been an In-line and the price target has been revised to $4. Analysts at Northland Capital downgraded the stock from ‘”an Outperform”‘ to ‘”a Market perform”‘ outlook in a report released in mid August. As of August 15, 2024, BofA Securities has decreased its “Neutral” rating to a “an Underperform” for CDLX. Earlier on August 08, 2024, Needham downgraded its rating. Their new recommendation was “a Hold” for CDLX stock which previously was a “a Buy”.
Analyzing CDLX Stock Performance
During the last five days, there has been a drop of approximately -6.38%. Over the course of the year, Cardlytics Inc shares have dropped approximately -52.56%. Shares of the company reached a 52-week high of $4.0450 on 01/24/25 and a 52-week low of $1.2200 on 04/08/25.
Support And Resistance Levels for Cardlytics Inc (CDLX)
According to the 24-hour chart, there is a support level at 1.6867, which, if violated, would cause prices to drop to 1.6133. In the upper region, resistance lies at 1.8017. The next price resistance is at 1.8433. RSI (Relative Strength Index) is 45.17 on the 14-day chart, showing neutral technical sentiment.
